Dynavax Technologies





Ebit Cambiamento Data
AbbVie USD 5.81B 4.36B 2025-12
Adma Biologics USD 49.19M 7.26M 2025-09
Agenus USD -13.31M 19.08M 2025-03
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Dynavax Technologies USD 21.27M 10.41M 2025-09
Gilead Sciences USD 2.96B 551M 2025-12
Glaxosmithkline GBP 3.76B 1.69B 2025-09
Merck USD 6.24B 1.32B 2025-12
Minerva Neurosciences USD -4.37M 1.71M 2024-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Novartis USD -9.19B 13.87B 2025-06
Pfizer USD 4.65B 71M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
TG Therapeutics USD 29.36M 5.48M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


Dynavax Technologies - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.